Big Molecule Watch
- Third Circuit Holds That Granting Discovery Under Section 1782 Is Not a “Final” Judgment June 13, 2025 Alison Siedor
- Sandoz Launches PYZCHIVA® (Ustekinumab) Autoinjector in Europe June 4, 2025 Christopher Cassella
- Samsung Bioepis Secures Marketing Approval in Korea for its Biosimilar to Amgen’s Bone Cancer Drug Xgeva June 3, 2025 Beth Ashbridge
- EMA Issues Positive CHMP Opinions for Fresenius Denosumab Biosimilars June 2, 2025 Sam Herron
- Celltrion, Samsung Bioepis, and Organon Receive Interchangeability Designations for Adalimumab Biosimilars June 2, 2025 Emma Murray
- FDA Approves Bio-Thera and Hikma’s Ustekinumab Biosimilar May 29, 2025 Riley Wyberg
- FDA Approves BLA for Novavax’s COVID-19 Vaccine May 23, 2025 Tara Thigpen
- Biogen Files Suit Against Neurimmune Over Rights to Bispecific Antibody May 21, 2025 Allegra Padula
- HyClone Seeks to Quash Amgen’s Subpoena Issued in Amgen/Accord Denosumab BPCIA Litigation May 21, 2025 Allegra Padula
- Regeneron Awarded $407 Million in Amgen Antitrust Suit May 19, 2025 Darlene Staines